Robert Moot
Impact in
- Oncology top 10%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Immunology top 10%
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
Papers in
- Oncology 6
- CAR-T cell therapy research 5
- Cancer Immunotherapy and Biomarkers 1
-
- Hemophilia Treatment and Research 3
- Co-authors
- Harold Trent Spencer (10 shared papers)Christopher B. Doering (10 shared papers)Sunil S. Raikar (4 shared papers)Andrew Fedanov (1 shared paper)Evan Joseph Colletti (2 shared papers)Christopher D. Porada (2 shared papers)Chad D. Sanada (2 shared papers)Graça D. Almeida-Porada (2 shared papers)
- Journals
- Blood (4 papers)Nature (2 papers)Gene Therapy (1 paper)OncoImmunology (1 paper)Experimental Hematology (1 paper)
- Partner nations
- United States
In The Last Decade
Robert Moot
12 papers receiving 567 citations
Robert Moot's Hit Papers
Peers
Comparison fields: 5 of 42
- Oncology 318
- Immunology 155
- Hematology 85
- Genetics 16
- Molecular Biology 97
Countries citing papers authored by Robert Moot
This map shows the geographic impact of Robert Moot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Moot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Moot more than expected).
Fields of papers citing papers by Robert Moot
This network shows the impact of papers produced by Robert Moot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Moot. The network helps show where Robert Moot may publish in the future.
Co-authors
The 21 scholars most cited alongside Robert Moot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Non-viral precision T cell receptor replacement for personalized cell therapy Hit paper breakdown → | 2022 | 214 |
| 2 | 2023 | 128 | |
| 3 | 2017 | 74 | |
| 4 | 2011 | 55 | |
| 5 | 2010 | 39 | |
| 6 | 2016 | 30 | |
| 7 | 2014 | 18 | |
| 8 | 2014 | 10 | |
| 9 | 2017 | 10 | |
| 10 | 2015 | 5 | |
| 11 | 2010 | 4 | |
| 12 | 2015 | 2 |
About Robert Moot
Robert Moot is a scholar working on Oncology, Hematology, Genetics, Biomedical Engineering and Nuclear Energy and Engineering, having authored 12 papers that have together received 589 indexed citations. Recurring topics across this work include CAR-T cell therapy research (5 papers), Hemophilia Treatment and Research (3 papers), Virus-based gene therapy research (2 papers), Microfluidic and Capillary Electrophoresis Applications (1 paper) and Cancer Immunotherapy and Biomarkers (1 paper). The work is most often cited by research in Oncology (318 citations), Immunology (155 citations), Hematology (85 citations), Genetics (16 citations) and Molecular Biology (97 citations). Robert Moot has collaborated with scholars based in United States. Frequent co-authors include Harold Trent Spencer, Christopher B. Doering, Sunil S. Raikar, Andrew Fedanov, Evan Joseph Colletti, Christopher D. Porada, Chad D. Sanada, Graça D. Almeida-Porada, Neal N. Iwakoshi and Shawn M. Jobe. Their work appears in journals such as Blood, Nature, Gene Therapy, OncoImmunology and Experimental Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.